BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sanaei M, Setayesh N, Sepehrizadeh Z, Mahdavi M, Yazdi MH. Nanobodies in Human Infections: Prevention, Detection, and Treatment. Immunol Invest 2020;49:875-96. [PMID: 31856615 DOI: 10.1080/08820139.2019.1688828] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Sasou A, Yuki Y, Kurokawa S, Sato S, Goda Y, Uchida M, Matsumoto N, Sagara H, Watanabe Y, Kuroda M, Sakon N, Sugiura K, Nakahashi-Ouchida R, Ushijima H, Fujihashi K, Kiyono H. Development of Antibody-Fragment-Producing Rice for Neutralization of Human Norovirus. Front Plant Sci 2021;12:639953. [PMID: 33868338 DOI: 10.3389/fpls.2021.639953] [Reference Citation Analysis]
2 Shajari S, Farajollahi MM, Behdani M, Tarighi P. Production and Conjugation of Truncated Recombinant Diphtheria Toxin to VEGFR-2 Specific Nanobody and Evaluation of its Cytotoxic Effect on PC-3 Cell Line. Mol Biotechnol 2022. [PMID: 35478310 DOI: 10.1007/s12033-022-00485-1] [Reference Citation Analysis]
3 Zebardast A, Hosseini P, Hasanzadeh A, Latifi T. The role of single-domain antibodies (or nanobodies) in SARS-CoV-2 neutralization. Mol Biol Rep 2021. [PMID: 34648139 DOI: 10.1007/s11033-021-06819-7] [Reference Citation Analysis]
4 Durmusoglu D, Catella CM, Purnell EF, Menegatti S, Crook NC. Design and in situ biosynthesis of precision therapies against gastrointestinal pathogens. Current Opinion in Physiology 2021;23:100453. [DOI: 10.1016/j.cophys.2021.06.007] [Reference Citation Analysis]
5 Ezzikouri S, Nourlil J, Tsukiyama-Kohara K, Kohara M, El Ossmani H, Windisch MP, Benjelloun S. Nanobodies: an unexplored opportunity to combat COVID-19. J Biomol Struct Dyn 2020;:1-3. [PMID: 33172342 DOI: 10.1080/07391102.2020.1845801] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
6 Bessalah S, Jebahi S, Mejri N, Salhi I, Khorchani T, Hammadi M. Perspective on therapeutic and diagnostic potential of camel nanobodies for coronavirus disease-19 (COVID-19). 3 Biotech 2021;11:89. [PMID: 33500874 DOI: 10.1007/s13205-021-02647-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 16.0] [Reference Citation Analysis]
7 Mu Y, Jia C, Zheng X, Zhu H, Zhang X, Xu H, Liu B, Zhao Q, Zhou EM. A nanobody-horseradish peroxidase fusion protein-based competitive ELISA for rapid detection of antibodies against porcine circovirus type 2. J Nanobiotechnology 2021;19:34. [PMID: 33526021 DOI: 10.1186/s12951-021-00778-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]